Literature DB >> 17088680

Can administration of metoclopramide reduce artefacts related to abdominal activity in myocardial perfusion SPECT?

Thomas Grüning1, Claudia Brogsitter, Mehrdad Khonsari, Ivor W Jones, Sue M Nevin, Wolfgang Burchert.   

Abstract

OBJECTIVES: Myocardial perfusion SPECT is frequently affected by artefacts related to abdominal activity. Metoclopramide has been suggested to relieve this, but two previous studies have shown conflicting results.
METHODS: Ninety-five patients received 10 mg metoclopramide orally after injection of 99mTc-tetrofosmin for the stress scan and 86 patients had metoclopramide after their rest injection. A control group of 82 patients did not receive metoclopramide. Scans were evaluated visually by three readers.
RESULTS: Metoclopramide given before the stress scan led to abdominal activity being visually better in 16 scans, worse in 10, and unchanged in 67 scans, compared to the same patient's rest scan without metoclopramide administration. Metoclopramide administered before the rest scan resulted in abdominal activity in 11 scans being visually better, in 19 worse, and 53 scans were deemed unchanged. These differences were not significant. The number of repeat stress or rest scans was not significantly different between patients who had received metoclopramide and those who had not. The administration of metoclopramide, irrespective of whether it was given before the stress or rest scan, made no significant difference to inferior wall-to-abdomen count ratio.
CONCLUSION: Neither qualitative nor quantitative analysis showed an effect of metoclopramide on abdominal activity in myocardial perfusion SPECT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088680     DOI: 10.1097/01.mnm.0000243368.73141.61

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  2 in total

1.  The prevalence and significance of increased gastric wall radiotracer uptake in sestamibi myocardial perfusion SPECT.

Authors:  Ali Gholamrezanezhad; Davoud Moinian; Mohammad Eftekhari; Sahar Mirpour; Hadi Hajimohammadi
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-04       Impact factor: 2.357

2.  Erythromycin as an alternative to reduce interfering extra-cardiac activity in myocardial perfusion imaging.

Authors:  M Vorster; M M Sathekge; P Rheeder
Journal:  Cardiovasc J Afr       Date:  2010 May-Jun       Impact factor: 1.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.